Concord Biotech Overview

  • Year Founded
  • 1984

Year Founded

  • Status
  • Public

  • Employees
  • 1,234

Employees

  • Stock Symbol
  • 543960

Stock Symbol

  • Share Price
  • $18.74
  • (As of Friday Closing)

Concord Biotech General Information

Description

Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Contact Information

Formerly Known As
Concord Control Systems Private Limited
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
BOM
Corporate Office
  • Mondeal Heights, Iscon Cross Road, S.G. Highway
  • 16th Floor, B-Wing
  • Ahmedabad, Gujarat 380015
  • India
+91 079 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Concord Biotech Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$18.74 $18.10 $10.83 - $19.92 $1.96B 105M 9.8K $0.35

Concord Biotech Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021
EV 1,814,777
Revenue 114,809 103,444 95,083 81,190
EBITDA 55,782 46,840 38,689 45,581
Net Income 36,885 29,899 23,478 31,571
Total Assets 184,405 173,127 161,009
Total Debt 0 3,842 8,241 12,156
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Concord Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Concord Biotech‘s full profile, request access.

Request a free trial

Concord Biotech Patents

Concord Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10294276-B2 Process for isolation of romidepsin from fermentation broth and preparation of crystals of romidepsin Active 04-Mar-2014 000000000 0
US-20170073374-A1 A process for isolation pf romidepsin from fermentation broth and preparation of crystals of romidepsin Active 04-Mar-2014 000000000 0
US-20160083764-A1 An improved process for the preparation of fidaxomicin Active 23-Apr-2013 0000000000 0
US-10119158-B2 Process for the preparation of fidaxomicin Active 23-Apr-2013 000000000 0
US-20070142424-A1 Process for producing tacrolimus (fk-506) using vegetable oil as sole source of carbon Inactive 29-Jul-2004 C12P17/188
To view Concord Biotech’s complete patent history, request access »

Concord Biotech Executive Team (3)

Name Title Board Seat Contact Info
Ankur Vaid Chief Executive Officer & Board Member
Sudhir Vaid Chairman & Board Member
Lalit Sethi Chief Financial Officer
To view Concord Biotech’s complete executive team members history, request access »

Concord Biotech Board Members (4)

Name Representing Role Since
0000000 0000000 Concord Biotech Board Member 000 0000
00000 0000 Concord Biotech Chief Executive Officer & Board Member 000 0000
00000000 00000000 Concord Biotech Board Member 000 0000
000000 0000 Concord Biotech Chairman & Board Member 000 0000
To view Concord Biotech’s complete board members history, request access »

Concord Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Concord Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Concord Biotech‘s full profile, request access.

Request a free trial

Concord Biotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view Concord Biotech’s complete esg history, request access »

Concord Biotech FAQs

  • When was Concord Biotech founded?

    Concord Biotech was founded in 1984.

  • Who is the CEO of Concord Biotech?

    Ankur Vaid is the CEO of Concord Biotech.

  • Where is Concord Biotech headquartered?

    Concord Biotech is headquartered in Ahmedabad, India.

  • What is the size of Concord Biotech?

    Concord Biotech has 1,234 total employees.

  • What industry is Concord Biotech in?

    Concord Biotech’s primary industry is Pharmaceuticals.

  • Is Concord Biotech a private or public company?

    Concord Biotech is a Public company.

  • What is Concord Biotech’s stock symbol?

    The ticker symbol for Concord Biotech is 543960.

  • What is the current stock price of Concord Biotech?

    As of 12-Apr-2024 the stock price of Concord Biotech is $18.74.

  • What is the current market cap of Concord Biotech?

    The current market capitalization of Concord Biotech is $1.96B.

  • What is Concord Biotech’s current revenue?

    The trailing twelve month revenue for Concord Biotech is $115M.

  • What is Concord Biotech’s annual earnings per share (EPS)?

    Concord Biotech’s EPS for 12 months was $0.35.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »